4.7 Article

New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 1, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00767-21

Keywords

binuclear cyclopalladated complex; cutaneous leishmaniasis; leishmanicidal activity; necrotic death; calcium homeostasis; mitochondria; Leishmania

Funding

  1. Sao Paulo Research Foundation (FAPESP) [2016/05345-4, 2016/177115, 2017/03552-5, 2018/23015-7, 2020/04415-4]
  2. Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas da UNESP (PADC)
  3. Thomas P. Infusino Endowment at Rutgers University
  4. FAPESP [2016/19289-9, 2019/21661-1, 2016/18191-5]
  5. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]
  6. National Council for Research and Development (CNPq)

Ask authors/readers for more resources

The study elucidates the mechanisms of action of an antileishmanial complex, which induces oxidative stress, cell cycle arrest, and apoptotic-like features in the parasite. Additionally, the complex shows effectiveness in reducing parasite load in Leishmania-infected rodents, suggesting its potential application in treating both cutaneous and visceral forms of the disease.
The current treatment of leishmaniasis is based on a few drugs that present several drawbacks, such as high toxicity, difficult administration route, and low efficacy. These disadvantages raise the necessity to develop novel antileishmanial compounds allied with a comprehensive understanding of their mechanisms of action. Here, we elucidate the probable mechanism of action of the antileishmanial binuclear cyclopalladated complex [Pd(dmba)(mu-N-3)](2) (CP2) in Leishmania amazonensis. CP2 causes oxidative stress in the parasite, resulting in disruption of mitochondrial Ca2+ homeostasis, cell cycle arrest at the S-phase, increasing the reactive oxygen species (ROS) production and overexpression of stress-related and cell detoxification proteins, and collapsing the Leishmania mitochondrial membrane potential, and promotes apoptotic-like features in promastigotes, leading to necrosis, or directs programmed cell death (PCD)-committed cells toward necrotic-like destruction. Moreover, CP2 reduces the parasite load in both liver and spleen in Leishmania infantum-infected hamsters when treated for 15 days with 1.5 mg/kg body weight/day CP2, expanding its potential application in addition to the already known effectiveness on cutaneous leishmaniasis for the treatment of visceral leishmaniasis, showing the broad spectrum of action of this cyclopalladated complex. The data presented here bring new insights into the CP2 molecular mechanisms of action, assisting the promotion of its rational modification to improve both safety and efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available